WeTrials
Active, not recruiting

A Pharmacodynamics-Driven Trial of Talazoparib, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Aberrations in Genes Involved in DNA Damage Response

What is this study?

This study tests a targeted cancer medicine called talazoparib in adults with advanced solid tumors. Researchers want to see if this medicine works for tumors that have specific changes in genes responsible for repairing DNA.

Who can participate?

Adults with advanced solid tumors who have specific genetic changes related to DNA repair may be able to join. Your doctors will check your test results to see if your cancer has the right gene changes for this study.

What will happen?

Participants will take the study drug talazoparib as a pill. Throughout the study, you will have regular check-ups, imaging scans, and provide small tissue or blood samples for lab testing.

Where and when?

This study has locations in Florida and Maryland in the United States. Please note that this study is currently active but not looking for new participants at this time.

Key Points
  • 1Tests the targeted cancer medicine talazoparib
  • 2Requires specific genetic changes in your tumor
  • 3Involves regular check-ups and imaging scans

No related links yet

Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Castration-Resistant Prostate CarcinomaClinical Stage III Gastric Cancer AJCC v8Clinical Stage IV Gastric Cancer AJCC v8HER2-Positive Breast CarcinomaLocally Advanced Breast CarcinomaLocally Advanced Gastric CarcinomaLocally Advanced Malignant Solid NeoplasmLocally Advanced Ovarian CarcinomaLocally Advanced Pancreatic CarcinomaLocally Advanced Prostate CarcinomaMetastatic Breast CarcinomaMetastatic Gastric CarcinomaMetastatic Malignant Solid NeoplasmMetastatic Ovarian CarcinomaMetastatic Pancreatic CarcinomaMetastatic Prostate CarcinomaPlatinum-Sensitive Ovarian CarcinomaRecurrent Breast CarcinomaRecurrent Gastric CarcinomaRecurrent Ovarian CarcinomaRecurrent Pancreatic CarcinomaRecurrent Prostate CarcinomaStage II Pancreatic Cancer AJCC v8Stage III Ovarian Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8Stage III Prostate Cancer AJCC v8Stage IV Ovarian Cancer AJCC v8Stage IV Pancreatic Cancer AJCC v8Stage IV Prostate Cancer AJCC v8

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.